Skip to main content
AHCO
NASDAQ Industrial Applications And Services

AdaptHealth Posts $154M Q3 Loss on $184.8M Goodwill Impairment; Free Cash Flow Collapses

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$6.28
Mkt Cap
$856.242M
52W Low
$5.21
52W High
$13.43
52W Position info
21% above low
Off High info
53% below high
Rel. Volume info
2.7× avg
Market data snapshot near publication time

AHCO sits 21% above its 52-week low of $5.21 on elevated volume (2.7× avg).

Summary

Revenue rose 10.9% to $745.6M in Q3, but a $184.8M non-cash goodwill impairment drove a $154M net loss, and nine-month free cash flow fell to $2.6M from $140.1M on heavy equipment spending.


Key Events · Earnings and Guidance · AHCO

  • Q3 Revenue Up 10.9%, Net Loss $154M

    Net revenue rose to $745.6M from $672.4M, but the quarter produced a net loss of $153.99M, or $1.13 per basic share, versus $0.17 of income a year earlier.

  • $184.8M Non-Cash Goodwill Impairment

    A sustained stock price decline triggered a quantitative test; Respiratory Health was written down $149.4M and Wellness at Home $35.4M. Nine-month impairment totals $329.0M. Sleep Health passed, but its fair value cushion over carrying value is under 20%.

  • Free Cash Flow Falls to $2.6M

    Nine-month free cash flow dropped to $2.6M from $140.1M as purchases of equipment and other fixed assets rose to $393.0M from $278.5M, largely to support capitated revenue arrangements.

  • Liquidity Tightens Ahead of Diabetes Sale

    Cash stood at $80.7M with negative working capital of $82.3M and $1.88B of debt; the $235.0M Diabetes Health sale is expected to close in Q1 2027 subject to regulatory approvals.


Analysis · AHCO · Industrial Applications And Services

Revenue grew 10.9% to $745.6M, yet the quarter ended in a $154M net loss after a $184.8M non-cash goodwill impairment on the Respiratory Health and Wellness at Home units, triggered by the sustained decline in the share price. The cash story is the real problem: nine-month free cash flow fell to $2.6M from $140.1M a year ago as capital spending on patient equipment jumped to $393.0M to support new at-risk capitated contracts. With only $80.7M of cash, negative working capital of $82.3M and $1.88B of debt, the $235M Diabetes Health sale — now expected to close in Q1 2027 — is the main lever to shore up the balance sheet. The filing also flags an October 2026 Medline field action pulling all Medline brand beds from the market, a new supply constraint.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, AHCO was trading at $6.28 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $856.2M. The 52-week trading range was $5.21 to $13.43. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AHCO - Latest Insights

AHCO
Nov 03, 2026, 7:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $5.91
Real-time Price: $7.40 info
Change: +$1.49 (+25%) info
Market Cap: $1.028B info
AHCO
Aug 04, 2026, 4:36 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $6.73
Real-time Price: $7.40 info
Change: +$0.670 (+10%) info
Market Cap: $1.028B info
AHCO
Aug 04, 2026, 7:58 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $7.90
Real-time Price: $7.40 info
Change: -$0.500 (-6%) info
Market Cap: $1.028B info
AHCO
Aug 04, 2026, 7:09 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $8.60
Real-time Price: $7.40 info
Change: -$1.20 (-14%) info
Market Cap: $1.028B info
AHCO
Jul 20, 2026, 4:37 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $11.17
Real-time Price: $7.40 info
Change: -$3.77 (-34%) info
Market Cap: $1.028B info